TPI Composites (TPIC) Q1 2025 Earnings Call May 12, 2025 05:00 PM ET Company Participants Jason Wegmann - Vice President of IR & ESGWilliam Siwek - President, CEO & DirectorRyan Miller - Chief Financial OfficerMark Strouse - Executive Director Conference Call Participants Luke Persons - Research AnalystJustin Clare - MD & Research Analyst Operator Greetings, and welcome to the TPI Composites First Quarter twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. A question ...

NuScale Power Corporation (SMR) Q1 2025 Earnings Call May 12, 2025 05:00 PM ET Company Participants Rodney McMahan - Senior Director - Investor RelationsJohn Hopkins - President and Chief Executive OfficerRamsey Hamady - CFOSherif Elmaghrabi - Equity Research AssociateCraig Shere - Director of Research Conference Call Participants Marc Bianchi - AnalystGeorge Gianarikas - Managing Director and Senior AnalystRyan Pfingst - Equity Research AnalystEric Stine - Senior Research Analyst Operator Good afternoon, a ...

Rigetti Computing (RGTI) Q1 2025 Earnings Call May 12, 2025 05:00 PM ET Company Participants Subodh Kulkarni - President & CEOJeffrey Bertelsen - CFOBrian Kinstlinger - MD, Director of Research & Head of Technology ResearchCraig Ellis - Director of Research Conference Call Participants David Williams - Equity Research AnalystQuinn Bolton - Senior AnalystNone - AnalystRichard Shannon - Senior Research Analyst Operator Thank you for standing by and welcome to the Rigetti Computing First Quarter twenty twenty ...

ZoomInfo (ZI) Q1 2025 Earnings Call May 12, 2025 05:00 PM ET Company Participants Jerry Sisitsky - VP, IRHenry Schuck - Founder, Chairman of the Board & CEOGraham O’Brien - Interim CFOMark Murphy - MD - Software ResearchElizabeth Porter - Executive DirectorRaimo Lenschow - Managing DirectorKash Rangan - Managing DirectorBrad Zelnick - Managing DirectorJackson Ader - Managing DirectorBrian Peterson - Managing DirectorAustin Cole - Software Equity Research AssociateRishi Jaluria - Managing DirectorAllan Verkh ...

Financial Data and Key Metrics Changes - Net sales from continuing operations totaled $24.7 million, down from $28 million in Q1 2024, reflecting broader market softness [4] - Adjusted EBITDA from continuing operations improved significantly, swinging from a loss of $2.7 million in the prior year to a positive $843,000 this quarter, marking a $3.5 million turnaround [5][20] - Gross profit nearly doubled to $4.8 million, or 19.3% of sales, compared to $2.3 million, or 8.3% last year, an expansion of over 1,100 basis points [17] Business Line Data and Key Metrics Changes - Tubular Segments generated $6.9 million in revenue, down slightly year over year, but gross margin increased from 12.3% to 24.8%, with adjusted EBITDA rising nearly five times to $1.3 million [6] - Specialty Chemicals segment revenue declined year over year to $17.8 million, but gross profit increased by $2.1 million, rising from $1.6 million to $3.7 million, a 131% improvement, with gross margin expanding from 7.6% to 21% [9] Market Data and Key Metrics Changes - Average daily trading volume increased to approximately 63,000 shares in Q1 2025, a 60% lift compared to Q1 2024, indicating growing market interest [13] Company Strategy and Development Direction - The company is focused on strategic repositioning, actively choosing to exit low-margin business in favor of higher value, more technically demanding opportunities [15][16] - The goal for the Specialty Chemicals segment is to shift from a 75% commodity and 25% blended mix to a 60% and 40% mix by the end of 2025, aiming for a more balanced portfolio [35] Management's Comments on Operating Environment and Future Outlook - Management noted that while there are signs of improvement, demand remains soft, and they are still evaluating options to monetize the value of their assets [28][29] - The company is not ready to provide forward-looking guidance for 2025, as they are still stabilizing their operations [30][31] Other Important Information - The company ended the quarter with $14.3 million in cash and no debt before the divestiture of Bristol assets for $45 million, providing significant flexibility for capital deployment [21][22] - The company repurchased approximately 17,000 shares at an average price of $12.73, reinforcing confidence in intrinsic value and long-term fundamentals [21] Q&A Session Summary Question: Comments on the ASTI business and its attractiveness as a target - Management indicated that while there are additional looks due to tariffs, demand remains incredibly soft, and the market conditions have not materially changed [28] Question: Possibility of selling ASTI in 2025 - Management confirmed they are always evaluating options to monetize the value of all assets [29] Question: Guidance for profitability in chemicals - Management stated it is premature to provide guidance as they are still stabilizing operations [30][31] Question: Growth plans for chemicals by 2026 - Management expects to see some growth in the second half of the year, with a more compelling top line anticipated in 2026 [33] Question: Capacity and CapEx for growth - Management confirmed that growth can be achieved with existing capacity and minimal CapEx, with a run rate of $1 to $3 million per year [36] Question: Stock buyback limitations - Management explained that the buyback was executed within the confines of the existing program, and optionality has increased post-Bristol sale [37] Question: Perception of stock valuation - Management expressed the opinion that the stock remains undervalued at current levels [38]

Hallador Energy Company (HNRG) Q1 2025 Earnings Call May 12, 2025 05:00 PM ET Company Participants Sean Mansouri - Founder & CEOBrent Bilsland - President, CEO & ChairmanMarjorie Hargrave - Chief Financial Officer Conference Call Participants Nick Giles - Senior Research Analyst Operator Good afternoon. Thank you for attending Hallador Energy's First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer ses ...

FiscalNote Holdings (NOTE) Q1 2025 Earnings Call May 12, 2025 05:00 PM ET Company Participants Bob Burrows - Investor RelationsJosh Resnik - President & CEOJon Slabaugh - CFO & CIOJesse Sobelson - VP - Equity Research Conference Call Participants Glenn Mattson - AnalystMike Latimore - Managing Director & Senior Research AnalystZach Cummins - Senior Research Analyst Operator Evening. My name is Pam, and I will be your conference operator today. At this time, I would like to welcome everyone to the FiscalNote ...

FibroGen (FGEN) Q1 2025 Earnings Call May 12, 2025 05:00 PM ET Company Participants Joanne Greller - Managing Director, IR CommunicationsThane Wettig - CEO & DirectorDavid DeLucia - CFOMatthew Keller - Equity Research Associate Conference Call Participants Andy Hsieh - Research Analyst, Healthcare Operator Please be advised today's conference is being recorded. I would now like to hand the conference over to your speaker today, Joanne Greller. Please go ahead. Joanne Greller Thank you, operator. Good aftern ...

Financial Data and Key Metrics Changes - The company generated $58 million in consolidated revenue for Q1 2025, representing a 14% year-over-year increase [8][25] - Adjusted EBITDA for the quarter was $9 million, up from $7 million in the same period last year, reflecting a 38% increase [8][26] - The company reported a net loss of $3 million on a GAAP basis, while adjusted net income was $3 million [26] Business Line Data and Key Metrics Changes - Revenue in the core Wealth Management and Capital Solutions segment rose 23% year-over-year, driven by a 10% increase in assets under management and advisement [8][25] - The Wealth and Capital Solutions segment generated $57 million in revenue, contributing significantly to overall growth [25] - Adjusted EBITDA for the Wealth and Capital Solutions segment was $19 million, reflecting a 34% margin [27] Market Data and Key Metrics Changes - The company closed the acquisition of Kontoora, marking its entry into Germany, the world's third-largest ultra-high-net-worth market [6][11] - Total assets in the Wealth and Capital Solutions segments reached approximately $82 billion, including around $32 billion managed through the international platform [12] Company Strategy and Development Direction - The company aims to become the leading independent global multifamily office and OCIO platform, focusing on strategic acquisitions and organic growth [6][18] - A zero-based budgeting approach is being implemented to align costs with strategic priorities and enhance operational efficiency [7][20] - The company is exiting non-core businesses to streamline operations and focus on high-conviction opportunities [7][22] Management's Comments on Operating Environment and Future Outlook - Management noted that despite market volatility, portfolios remained resilient due to broad diversification across asset classes [17][18] - The company is optimistic about growth opportunities in Germany and the strong organic pipeline in the U.S. [39][40] - Management emphasized the importance of aligning investments with clients' values, highlighted by the launch of the Alti Global Social Progress Index [19][20] Other Important Information - The company ended the quarter with $52 million in cash and no debt, evaluating financing alternatives for future growth [29][30] - The company is advancing its marketing strategy with a focus on segmentation to better resonate with client needs [15][16] Q&A Session Summary Question: Can you discuss the zero-based budgeting efforts and provide a timeline for expected reductions? - Management indicated that the zero-based budgeting process is a line-by-line review across all segments, with implementation already underway [34][35] - More detailed quantification of cost savings is expected to be provided in August [36] Question: What are the expectations for growth in Germany and the M&A pipeline? - Management expressed optimism about the German market, highlighting the successful acquisition of Kontoora and ongoing client engagements [38][39] - The M&A pipeline includes both individual team lift-outs and organizations in various markets, with a strong organic growth pipeline as well [40] Question: Can you provide details on the real estate business and its near-term direction? - The company is divesting from its international real estate segment, focusing on core wealth management operations, with a definitive plan expected by the next call in August [44] Question: How is the company navigating market volatility and its impact on AUM? - Management remains relatively sanguine about market volatility, emphasizing a balanced asset approach and the ability to adapt to changing conditions [46][47]

Coherus BioSciences (CHRS) Q1 2025 Earnings Call May 12, 2025 05:00 PM ET Company Participants Jodi Sievers - Vice President of Investor Relations & Corporate CommunicationsDennis Lanfear - Chairman, President & CEOTheresa Lavallee - Chief Scientific & Development OfficerRosh Dias - Chief Medical OfficerSameer Goregaoker - EVP - CommercialBryan McMichael - CFOKripa Devarakonda - Vice President - Biotechnology Equity ResearchMichael Nedelcovych - Director - Equity Research Conference Call Participants Brian ...